Medication

This undated photo provided by Esperion Inc. shows the cholesterol-lowering drug Nexletol made by Esperion Therapeutics Inc. The Food and Drug Administration on Friday, Feb. 21, 2020 approved Esperion Therapeutics Inc.’s Nexletol for people genetically predisposed to have sky-high cholesterol and others who have heart disease and need to further lower their bad cholesterol.(Esperion Inc. via AP)
Associated Press
February 21, 2020 - 4:41 pm
TRENTON, N.J. (AP) — U.S. regulators on Friday approved a new type of cholesterol-lowering drug aimed at millions of people who can't tolerate — or don't get enough help from — widely used statin pills like Lipitor and Crestor. The Food and Drug Administration approved Esperion Therapeutics Inc.’s...
Read More
This undated photo provided by MIT/Langer Lab shows a star-shaped gastric resident dosage form of birth control that can be folded into a standard capsule and orally ingested. The dosage form resides in the stomach for up to a month where it releases the contraceptive drug.​ (Paramesh Karandikar/MIT/Langer Lab via AP)
Associated Press
December 04, 2019 - 2:05 pm
WASHINGTON (AP) — Birth control pills work great if women remember to take them every day but missing doses can mean a surprise pregnancy. Now scientists have figured out how to pack a month’s supply into one capsule. The trick: A tiny star-shaped gadget that unfolds in the stomach and gradually...
Read More
October 22, 2019 - 10:15 pm
WASHINGTON (AP) — A powerful House panel has approved House Speaker Nancy Pelosi's legislation to lower prescription drug prices for seniors and working-age people. The Ways and Means committee voted Tuesday along party lines, moving the bill closer to floor action. It fulfills a long-sought...
Read More
FILE- This Nov. 14, 2018, file photo shows Lubriderm, a Johnson & Johnson product, on display at a market in Pittsburgh. Johnson & Johnson reports financial results Tuesday, Oct. 14, 2019. (AP Photo/Gene J. Puskar, File)
October 15, 2019 - 8:37 am
NEW BRUNSWICK, N.J. (AP) — Johnson & Johnson's third-quarter profit jumped 23%, beating Wall Street forecasts, thanks to higher sales of its key medicines for cancer and immune disorders and an acquisition-related charge a year earlier. The world's biggest maker of health care products also...
Read More
FILE - In this Sept. 12, 2019, file photo, cars pass Purdue Pharma headquarters in Stamford, Conn. How much members of the Sackler family should be held accountable for the role their company, Purdue Pharma, played in the nation’s opioid crisis will be at the center of a hearing in federal bankruptcy court. State attorneys general who are pressing separate state claims against the Sacklers want their cases to continue even as Purdue’s bankruptcy case plays out. They will make that argument on Friday, Oct. 11, 2019 before a bankruptcy judge in White Plains, New York. (AP Photo/Frank Franklin II, File)
October 11, 2019 - 8:02 pm
WHITE PLAINS, N.Y. (AP) — A judge is pushing for a settlement of more than 2,600 lawsuits facing OxyContin maker Purdue Pharma with a decision Friday to pause litigation against the company and members of the wealthy Sackler family that owns the company. In a hearing Friday, U.S. Bankruptcy Judge...
Read More
FILE - In this July 30, 2013, file photo, people walk along a corridor at the headquarters of Johnson & Johnson in New Brunswick, N.J. A Philadelphia jury has ruled that Johnson & Johnson and Janssen Pharmaceuticals must pay $8 billion in punitive damages over an antipsychotic drug linked to the abnormal growth of female breast tissue in boys. A law firm for the plaintiff released a statement Tuesday, Oct. 8, 2019, saying the companies used an organized scheme to make billions of dollars while illegally marketing and promoting the drug called Risperdal. (AP Photo/Mel Evans, File)
October 08, 2019 - 8:27 pm
PHILADELPHIA (AP) — A Philadelphia jury on Tuesday awarded $8 billion in punitive damages against Johnson & Johnson and one if its subsidiaries over a drug the companies made that the plaintiff's attorneys say is linked to the abnormal growth of female breast tissue in boys. Johnson and Johnson...
Read More
Professor Gregg Semenza, accompanied by Johns Hopkins University President Ron Daniels, waves to the crowd during a news conference after he was awarded the 2019 Nobel Prize in Medicine at Johns Hopkins Medicine Hospital in Baltimore, Md., Monday, Oct. 7, 2019. The 2019 Nobel Prize in Medicine has been jointly awarded to William Kaelin Jr., Sir Peter Ratcliffe and Gregg Semenza for their pioneering research into how human cells respond to changing oxygen levels. (AP Photo/Jose Luis Magana)
Associated Press
October 07, 2019 - 8:35 pm
NEW YORK (AP) — Two Americans and a British scientist won a Nobel Prize on Monday for discovering details of how the body's cells sense and react to low oxygen levels, providing a foothold for developing new treatments for anemia, cancer and other diseases. Drs. William G. Kaelin Jr. of Harvard...
Read More
This undated photo provided by Johns Hopkins University shows Gregg L. Semenza at the university in Baltimore. Semenza, a Johns Hopkins University researcher, was awarded the Nobel Prize for Physiology or Medicine on Monday, Oct. 7, 2019. He will share the prize with Drs. William G. Kaelin Jr. and Peter J. Ratcliffe for their discoveries of how cells sense and adapt to oxygen availability, the Nobel Committee announced Monday. (Johns Hopkins University via AP)
October 07, 2019 - 8:48 am
STOCKHOLM (AP) — The Latest on the Nobel Prize in Medicine or Physiology (all times local): 2:40 p.m. Dr. Gregg Semenza, a top researcher at Johns Hopkins University in Baltimore, says he was awakened by a call from Stockholm shortly before 4 a.m. with the good news that he is one of three...
Read More
FILE - In this Sept. 12, 2019, file photo, cars pass Purdue Pharma headquarters in Stamford, Conn. How much members of the Sackler family should be held accountable for the role their company, Purdue Pharma, played in the nation’s opioid crisis will be at the center of a hearing in federal bankruptcy court. State attorneys general who are pressing separate state claims against the Sacklers want their cases to continue even as Purdue’s bankruptcy case plays out. They will make that argument on Friday, Oct. 11, 2019 before a bankruptcy judge in White Plains, New York. (AP Photo/Frank Franklin II, File)
October 04, 2019 - 5:26 pm
Attorneys general representing nearly half the states and lawyers for more than 500 local governments on Friday blasted the terms of Purdue Pharma's offer to settle thousands of lawsuits over the nation's opioid crisis in court filings that also said the company had funneled up to $13 billion to...
Read More
FILE - In this July 30, 2013, file photo, large banners hang in an atrium at the headquarters of Johnson & Johnson in New Brunswick, N.J. Johnson & Johnson has become the latest company to settle a lawsuit to get out of the first federal trial over the nation's opioids crisis, reaching a deal worth more than $20 million with two Ohio counties, the company announced Tuesday, Oct. 1, 2019. (AP Photo/Mel Evans, File)
Associated Press
October 01, 2019 - 9:28 pm
Johnson & Johnson on Tuesday announced it had reached an agreement worth more than $20 million with two Ohio counties, becoming the latest company to settle a lawsuit to get out of the first federal trial over the nation's opioids crisis. The deal with Cuyahoga and Summit counties comes a...
Read More

Pages